About
Small Molecules, Biologics
Areas of Focus
Categories
Biologics & BiopharmaceuticalSmall Molecule PharmaceuticalAntibodyJapan
Clinical Trials (14)
View allTotal Trials
14
As Lead Sponsor
2
As Collaborator
12
Total Enrollment
496
By Phase
PHASE1/PHASE2: 2PHASE2: 7PHASE1: 2PHASE3: 2PHASE4: 1
By Status
COMPLETED: 8RECRUITING: 3ACTIVE_NOT_RECRUITING: 2TERMINATED: 1
Clinical Trials Pipeline14 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06053814Collaborator
NS-050/NCNP-03 in Boys With DMD (Meteor50)
PHASE1/PHASE2Recruiting
20 participants
Started: Sep 18, 2024 · Completed: May 31, 2027
NCT05996003Collaborator
NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD)
PHASE2Recruiting
20 participants
Started: Feb 22, 2024 · Completed: Sep 11, 2026
NCT06046222Collaborator
Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis
PHASE2Recruiting
45 participants
Started: Dec 20, 2023 · Completed: Jul 31, 2026
NCT06670898Lead Sponsor
A Study of Absorption, Metabolism, Excretion of [14C]-NS-580 in Healthy Male Subjects
PHASE1Completed
8 participants
Started: Nov 8, 2023 · Completed: Jan 18, 2024
NCT04854096Collaborator
Study to Assess Efficacy and Safety of NS-018 Compared to BAT in Patients With Myelofibrosis
PHASE2Terminated
7 participants
Started: Jan 31, 2023 · Completed: May 16, 2024
Locations (1)
Headquarters
Kyoto, Japan
Map
Loading map...